Related by context. All words. (Click for frequent words.) 79 Gastric Cancer 78 Renal Cell Carcinoma 78 Advanced Melanoma 77 Prolongs Survival 77 Chronic Hepatitis B 76 Clinical Trial Results 76 Oral Fingolimod 76 Myelodysplastic Syndromes 76 Malignant Melanoma 75 Rheumatoid Arthritis Patients 75 Clinical Outcome 75 Pulmonary Arterial Hypertension 75 Adjuvant Treatment 75 Antitumor Activity 75 Chronic Heart Failure 75 Severe Sepsis 74 Metastatic Melanoma 74 Pooled Analysis 74 Phase 2b Clinical Trial 74 Prospective Randomized 74 Metastatic Prostate Cancer 74 Rotavirus Vaccine 74 Benign Prostatic Hyperplasia 74 Venous Thromboembolism 74 Brain Metastases 74 Adjuvant Chemotherapy 74 Unresectable 74 HER2 Positive Breast Cancer 74 Atopic Dermatitis 73 Combination Therapy 73 Bazedoxifene 73 Combination Treatment 73 Bladder Cancer 73 Patients Treated With 73 Drug Resistant 73 Advanced Renal Cell 73 Disease Progression 73 Randomized Study 73 Improves Survival 73 Treating Chronic 73 Endometrial Cancer 73 Colorectal Cancer Patients 73 Virus Infection 73 Phase III Clinical Trial 73 Hypercholesterolemia 73 Inflammatory Markers 73 Antitumor 73 Proves Effective 73 Chronic Hepatitis C 73 Metastatic Colorectal Cancer 73 Myelofibrosis 73 Relapsing Multiple Sclerosis 73 Diabetic Nephropathy 73 Tyrosine Kinase Inhibitor 73 Drug Candidate 73 Chronic Lymphocytic Leukemia 73 Hormone Refractory Prostate Cancer 73 Malignancies 73 Sipuleucel T 73 Anticancer Drug 73 Kinase Inhibitors 72 Diabetic Neuropathy 72 Anti Tumor 72 Study Evaluating 72 Hepatitis C Virus 72 Improves Outcomes 72 Immunotherapeutic 72 Efficacy Trial 72 Elderly Patients 72 Overactive Bladder 72 Shows Promise Against 72 Skeletal Muscle 72 Controlled Trial 72 Vaccine Candidate 72 Shows Promising 72 Interferon Alpha 72 Survival Benefit 72 Fungal Infections 72 Appears Safe 72 Invasive Breast Cancer 72 Preclinical Models 72 Adjuvant Therapy 72 Relapsed Refractory 72 Chronic Sinusitis 72 Chronic Myeloid Leukemia 72 Subgroup Analysis 72 Investigational Treatment 72 Meets Primary Endpoint 72 Shows Efficacy 72 Liver Cancer 72 Allogeneic 72 Cutaneous T 72 Hepatitis B Vaccine 72 Breast Cancer Recurrence 72 Gastrointestinal Stromal Tumors 72 Prognostic Factors 72 Cancer Treatments 72 Antiviral Therapy 72 See CLINICAL PHARMACOLOGY 72 Secondary Hyperparathyroidism 72 Oral Mucositis 72 Autoimmune Disease 72 Allergic Rhinitis 72 Hsp# Inhibitor 72 Topical Treatment 72 Dose Escalation 72 HER2 Positive 72 Novel Therapeutic 72 Newly Diagnosed Multiple Myeloma 72 Initiate Clinical Trial 72 Phase 2b Study 71 Iron Overload 71 Renal Cancer 71 Cell Lymphoma 71 Novel Mechanism 71 Ischemic Stroke 71 Lymphocytic 71 Pharmacokinetic Study 71 Initiates Clinical Trial 71 Cancer Vaccines 71 Receives Orphan Drug Designation 71 Preclinical Study 71 JAK Inhibitor 71 Advanced Pancreatic Cancer 71 Demonstrates Sustained 71 Ovarian Cancer Patients 71 Patients Undergoing 71 Beneficial Effects 71 Placebo Controlled Study 71 Autoimmune Diseases 71 Patients Suffering 71 Estrogen Receptor 71 Stem Cell Treatment 71 RNAi Therapeutic 71 Improve Survival 71 Phase 2a Clinical Trial 71 Glatiramer Acetate 71 Emerging Therapies 71 Lupus Nephritis 71 Hypertensive Patients 71 Phase IIb Clinical Trial 71 Therapeutic Vaccine 71 Transdermal Patch 71 Interferon Beta 71 Fondaparinux 71 Improved Survival 71 Mouse Model 71 Analytical Tool 71 Immune Responses 71 Epidermal Growth Factor Receptor 71 Laryngeal Cancer 71 Thromboembolism 71 Pafuramidine 71 Node Positive 71 Phase 2b Trial 71 Long Term Efficacy 71 Prostate Cancer Patients 71 Lung Cancer Trial 71 Proven Effective 71 Kidney Transplant Patients 71 Phase IIb Trial 71 Unfractionated Heparin 71 Patients Treated 71 Phase III Clinical Trials 71 Cardiotoxicity 71 Leukemias 71 Hepatitis B Virus 71 Nilotinib 71 Neuroprotection 71 Gene Mutation 71 Intracerebral Hemorrhage 71 Drug Shows Promise 71 Acute Ischemic Stroke 71 Progenitor Cells 71 Targeted Therapies 71 Dendritic Cells 71 Inflammatory Diseases 71 Lung Cancer Drug 71 Therapeutic Vaccines 71 Pneumococcal Vaccine 71 Stomach Cancer 71 II Clinical Trial 70 Enlarged Prostate 70 Non Invasive Treatment 70 Multiple Myeloma Patients 70 Pediatric Patients 70 Randomized Controlled Trials 70 Osteoporosis Treatment 70 Meta Analysis 70 Patients Receiving 70 Previously Treated 70 Phase 2a Trial 70 Lupus Drug 70 Localized Prostate Cancer 70 Soft Tissue Sarcoma 70 Surgical Treatment 70 Progressive Multifocal Leukoencephalopathy 70 Colorectal Adenomas 70 Peptic Ulcer 70 Inhaled Corticosteroids 70 Uterine Fibroid Embolization 70 Breast Cancer Cells 70 Kidney Function 70 Solid Tumors 70 HDAC Inhibitor 70 Prostate Cancer Vaccine 70 Breast Cancer Metastasis 70 Lung Cancer Patients 70 Hormone Receptor Positive 70 Neoadjuvant Chemotherapy 70 Smallpox Vaccine 70 Seasonal Influenza Vaccine 70 Viral Infections 70 Follicular Lymphoma 70 Personalized Immunotherapy 70 FOLOTYN ® 70 Ischemic 70 Iron Deficiency 70 Therapeutic Potential 70 IIa Clinical Trial 70 Genes Predict 70 Prostate Cancer Treatment 70 Randomized Phase 70 Pivotal Study 70 Eculizumab 70 Atypical Hemolytic Uremic Syndrome 70 Clostridium difficile Infection 70 Investigational Compound 70 Breast Tumors 70 Newly Diagnosed 70 Postmenopausal Women 70 Bivalirudin 70 Systematic Review 70 Chronic Renal Failure 70 Subtypes 70 Controlled Study 70 Anti Tumor Activity 70 Combination REOLYSIN R 70 Neuroendocrine Tumors 70 Oral Insulin 70 Oral Cavity 70 ThermoDox R 70 Anticancer Agent 70 Slow Progression 70 Single Dose 70 Phase III Trial 70 Demonstrates Efficacy 70 Previously Untreated 70 Angiogenic 70 Artery Disease 70 Recurrent Breast Cancer 70 Gene Linked 70 Lymphoid 70 Adenoma 70 Investigational Drug 70 Randomized Phase II 70 Inflammatory Arthritis 70 Tezampanel 70 Adult Stem Cell Therapy 70 Inflammatory Disease 70 Tyrosine Kinase Inhibitors 70 Knee Osteoarthritis 70 Placebo Controlled Trial 70 Preclinical Data 70 Antiviral Activity 70 Novel Oral 70 Pivotal Phase III 70 Tigecycline 70 Genetic Variation 70 Autologous Stem Cell Transplantation 70 Serious Infections 70 Recombinant Human 70 Radiofrequency Ablation 70 Estrogen Therapy 70 Advanced Prostate Cancer 70 Vaccine Adjuvant 70 Trial Evaluating 70 Protein Involved 70 Breast Cancer Treatment 70 Experimental Vaccine 70 Monoclonal Antibodies 70 Novel Treatments 70 Dose Ranging Study 70 HCV Protease Inhibitor 70 Randomized Trials 70 Kinase Inhibitor 70 Glioma 70 Pivotal Trial 70 Antiplatelet Therapy 70 Severe Asthma 70 Chemotherapeutic Agents 70 First Patient Dosed 70 Diabetic Patients 70 Anthracycline 70 Liver Cirrhosis 70 Neoplasms 70 Myelodysplastic Syndrome MDS 70 Cetrorelix 70 Treated Patients 70 Novel Inhibitor 70 Juvenile Idiopathic Arthritis 70 Fabry Disease 70 Advanced Colorectal Cancer 70 Successfully Completes Phase 70 Reduces Mortality 70 Acute Heart Failure 70 Renal Function 70 Diabetic Foot Ulcer 69 Bosutinib 69 Systemic Sclerosis 69 Heart Failure Patients 69 Schizophrenia Treatment 69 Erectile Dysfunction Drug 69 NDA Submission 69 Preterm Delivery 69 Tumor Targeting 69 Patient Enrollment 69 Randomized Double Blind 69 Monoclonal Antibody 69 Lowers Risk 69 Cardiovascular Events 69 Novel Antibiotic 69 Radioimmunotherapy 69 Dengue Virus 69 Metabolic Disease 69 Complicated Skin 69 Peripheral Blood 69 Non Alcoholic Fatty 69 Immune Mediated 69 Drug Prevents 69 Cardiovascular Disease Risk 69 Drug Combo 69 Venous Thrombosis 69 Hematopoietic 69 Small Intestine 69 Dupuytren Contracture 69 Resistant Hypertension 69 IND Application 69 RNAi Therapeutics 69 Safinamide 69 Phase III Trials 69 Systemic Lupus Erythematosus 69 Immune Cell 69 Elagolix 69 Acute Myocardial Infarction 69 TB Vaccine 69 Protein Linked 69 Sustained Efficacy 69 Insulin Resistance 69 Clinical Efficacy 69 Small Molecule 69 Breast Density 69 Phase IIa Clinical Trial 69 Immunogenicity 69 Gout Drug 69 Chemoradiation 69 Neural Stem Cells 69 Malaria Vaccine 69 Castration Resistant Prostate Cancer 69 Pirfenidone 69 Completes Patient Enrollment 69 Metastases 69 Fracture Risk 69 Interferon Alfa 69 Hepatocellular Carcinoma HCC 69 Postmenopausal 69 Slows Progression 69 Smooth Muscle 69 Liver Failure 69 Growth Hormone Deficiency 69 Confirms Efficacy 69 Metabolic Disorder 69 Mouse Models 69 Neoadjuvant 69 Nymox NX 69 Carcinoma 69 Premature Infants 69 Molecular Basis 69 Orally Active 69 Esophageal Cancer 69 Urinary Incontinence 69 Cholesterol Lowering Drug 69 Prophylactic Treatment 69 Lung Cancer Treatment 69 Valve Replacement 69 Early Diagnosis 69 Genes Linked 69 Vitro Activity 69 FDA Approvals 69 Thromboembolic 69 Effectively Treats 69 Osteoporosis Drugs 69 Infected Patients 69 Immunosuppression 69 Effective Treatments 69 Antiangiogenic 69 Invasive Fungal Infections 69 Plus Ribavirin 69 Oral Formulation 69 Systemic Delivery 69 Adefovir 69 Tumor Response 69 Therapeutic Antibodies 69 invasive candidiasis 69 Double Blind Randomized 69 Stakeholder Opinions 69 Decitabine 69 Lung Cancer Survival 69 Epilepsy Drug 69 Autoimmune Disorders 69 Demonstrates Significant 69 Pivotal Clinical Trial 69 Antibiotic Resistant 69 Gastrointestinal Disorders 69 Male Infertility 69 Clinical Trial Evaluating 69 Transdermal Delivery 69 Neoplasia 69 Ovarian Cancers 69 Influenza Vaccine 69 Glufosfamide 69 Breast Carcinoma 69 Breast Cancer Survival 69 Therapeutic Efficacy 69 Septic Shock 69 Granted Orphan Drug 69 Cell Transplants 69 Clinical Trial Data 69 Inhibits 69 Therapeutic Effects 69 Genes Identified 69 Minimally Invasive Treatment 69 Acute Renal Failure 69 Malignant Glioma 69 Treatment Naive Patients 69 Phase 1b Clinical Trial 69 Metastatic Renal Cell Carcinoma 69 Influenza Virus 69 Respiratory Virus 69 Bone Metastases 69 Alemtuzumab 69 Idiopathic Pulmonary Fibrosis 68 Radiation Induced 68 Diabetic Neuropathic Pain 68 Antiplatelet 68 Nicotine Vaccine 68 ACE Inhibitors 68 Rectal Cancer 68 Nitazoxanide 68 Investigational Agent 68 Initiates Clinical 68 Carotid Stenting 68 Arterial Disease 68 Carcinoid 68 Respiratory Distress 68 Psoriasis Patients 68 Chronic Myelogenous Leukemia 68 Eluting Stent 68 Demonstrates Potent 68 Androgen Deprivation Therapy 68 Naive Patients 68 Successfully Treats 68 Osteoporosis Drug 68 Cell Proliferation 68 Teva Provides Update 68 Therapeutic Targets 68 Treatment Resistant 68 Therapeutic Antibody 68 Acute Coronary Syndromes 68 Phase III Pivotal 68 Natalizumab 68 Anti CD# Antibody 68 Myeloma Patients 68 Replacement Therapy 68 Cognitive Impairment 68 Myocardial Ischemia 68 Signaling Pathway 68 Peginterferon 68 Diagnostic Tests 68 Hematological Malignancies 68 Is Well Tolerated 68 Intracranial Aneurysms 68 Protease Inhibitor 68 Oral Interferon 68 Confirmatory Phase 68 Microalbuminuria 68 Cancer Stem Cells 68 Fewer Side Effects 68 Hepatic Encephalopathy 68 Risk Stratification 68 Thyroid Hormone 68 JAK2 Inhibitor 68 Genetic Mutation 68 Aurora Kinase 68 Tumor Suppressor Gene 68 Prolongs Life 68 Sevelamer 68 Cytotoxicity 68 Systemic Lupus Erythematosus SLE 68 Immunosuppressant 68 FDA Approves Drug 68 Image Guided 68 Treatment Naive 68 Cognitive Deficits 68 Lubiprostone 68 Diabetic Macular Edema 68 Randomized Clinical Trial 68 Randomized Clinical Trials 68 Vascular Inflammation 68 B Cell Lymphoma 68 Portal Hypertension 68 Hematological Cancers 68 complement inhibitor eculizumab 68 Thyroid Cancer 68 Pivotal Phase 68 Peripheral Artery Disease 68 Predict Risk 68 Insulin Glargine 68 Capecitabine 68 Epitopes 68 Hospital Acquired Pneumonia 68 Randomized Double blind 68 Endovascular Treatment 68 Patient Outcomes 68 Multicenter Randomized 68 Novel Vaccine 68 Present Preclinical Data 68 Postmenopausal Osteoporosis 68 Telbivudine 68 Intravenous Formulation 68 Cardiovascular Outcomes 68 Double Blind Placebo 68 Randomized Double Blind Placebo 68 Monotherapy 68 Bucindolol 68 Carotid Endarterectomy 68 Radical Prostatectomy 68 IND Filing 68 Antiviral Drugs 68 Radiofrequency Ablation RFA 68 Aggressive Prostate Cancer 68 Adjunctive Therapy 68 Treating Heart Failure 68 Ranolazine 68 Combo Therapy 68 Innate Immune 68 essential thrombocythemia ET 68 XYOTAX TM 68 Polymerase Inhibitor 68 Syncria R 68 Critically Ill Patients 68 Adjuvant Breast Cancer 68 Liver Tumors 68 Clinical Evaluation 68 Parathyroid Hormone 68 Pivotal Trials 68 Trastuzumab 68 Deforolimus 68 Neulasta ® 68 SARS Virus 68 Insulin Sensitivity 68 Thrombus 68 Protease Inhibitors 68 Nonalcoholic Fatty Liver Disease 68 Statin Therapy 68 Ridaforolimus 68 Genes Involved 68 Prostatic 68 Beta Blocker 68 Oligonucleotides 68 Relapsing Remitting Multiple Sclerosis 68 Metastatic Disease 68 Efficacious 68 Myoblast 68 Dyslipidemia 68 Therapy Shows Promise 68 Statin Drugs 68 Daclizumab 68 Treatment Shows Promise 68 Skin Cancers 68 Stent Restenosis 68 Drug Eluting 68 Menopausal Symptoms 68 Treating Prostate Cancer 68 Taxane 68 Novel Therapies 68 Presents Preclinical Data 67 Cellular Immunotherapy 67 Aliskiren 67 Erlotinib 67 Renal Insufficiency 67 Conjugate 67 Lung Tumors 67 Targeted Therapy 67 Stent Thrombosis 67 Predict Response 67 Differential Diagnosis 67 Radiation Treatment 67 Guidelines Issued 67 Tanespimycin 67 Respiratory Syncytial Virus 67 Epratuzumab 67 Dasatinib 67 C1 Inhibitor 67 Etiology 67 Genetic Variant 67 Myelodysplastic Syndrome 67 Neuroprotective Effects 67 Vaccine Protects Against 67 Adenoviral 67 Prognostic Significance 67 Reduced Risk 67 Successfully Treated 67 Randomized Controlled Trial 67 ST Elevation Myocardial 67 Infarct 67 Retrovirus 67 Mimetics 67 Renal Cell Carcinoma RCC 67 Hepatocellular 67 Catheter Ablation 67 Genetic Predisposition 67 HCV Infection 67 Obese Patients 67 Reflux Disease 67 Squamous 67 Statistically Significant 67 Hyperlipidemia 67 Symptom Relief 67 Renal Failure 67 Files IND 67 Fixed Dose 67 Chronic Constipation 67 Respiratory Infections 67 Blocked Arteries 67 Electrophysiology Mapping 67 Apaziquone 67 Breast Tumor 67 Aggressive Reduction 67 Chronic Liver Disease 67 Demonstrates Positive 67 Increased Mortality 67 Tiotropium 67 Advanced Solid Tumors 67 Chronic Pelvic Pain 67 Bortezomib 67 Hemodialysis Patients 67 Treatment Regimen 67 Degarelix 67 Refractory Angina 67 Cell Transplant 67 Bone Marrow Transplants 67 Non Inferiority 67 Acute Liver Failure 67 Genes Associated 67 Coronary Artery Bypass Graft 67 Surgical Procedures 67 Cell Adhesion 67 Chemokine Receptor 67 Critical Limb Ischemia CLI 67 Squamous Cell Carcinoma 67 Melphalan 67 Pertuzumab 67 Xenografts 67 Neovascular Age Related Macular 67 Bacterial Infections 67 Novel Small Molecule 67 Irinotecan 67 Tesamorelin 67 Coronary Arteries 67 Inactivated 67 Dual Antiplatelet Therapy 67 Osteoporotic 67 Peripheral Arterial 67 Vertebral Fractures 67 Urinary Tract Infections 67 Pegylated Interferon 67 Pharmacokinetics PK 67 Treatment Reduces 67 Androgen Independent 67 Chronic lymphocytic leukemia 67 Well Tolerated 67 Oncologic 67 Eye Diseases 67 Lung Cancers 67 Tumor Growth 67 Kidney Transplantation 67 Shown Effective 67 FDA Okays 67 Contrast Agents 67 Potent Inhibitor 67 Demonstrates Potential 67 Hemorrhagic Stroke 67 Diagnostic Criteria 67 Gene Mutations 67 Multicenter Study 67 Chronic HCV 67 Prognostic Value 67 Critical Limb Ischemia 67 Potentially Fatal 67 Dose Escalation Study 67 Gene Variants 67 Low Dose 67 TNF Blockers 67 Periodontal Disease 67 Liver Metastases 67 lexidronam injection 67 Skin Lesions 67 Suicidality 67 Prophylaxis 67 Soy Isoflavones 67 Oncolytic 67 Oral Presentations 67 Metastatic 67 Pulmonary Arterial Hypertension PAH 67 Viral Suppression 67 Synthetic Peptide 67 Initiate Phase 67 Pemphigus Vulgaris 67 Denufosol 67 Stakeholder Insight 67 Bone Fractures 67 Treatment Experienced 67 Data Suggest 67 Antigen Specific 67 Hematologic 67 Valopicitabine 67 Dose Response 67 Hormone Replacement 67 Breast Cancer Patients 67 Randomized Evaluation 67 Diastolic Heart Failure 67 Anticancer Drugs 67 Bipolar Mania 67 Osteoarthritis Patients 67 Paraplatin ® 67 Golimumab 67 Transcription Factor 67 Begin Clinical Trials 67 Aortic Stenosis 67 Completes Enrollment 67 Initiates Phase III 67 Sleep Disturbances 67 Nuclear Receptors 67 Psoriasis Drug 67 Wound Dressing 67 Faropenem 67 Genetic Variations 67 Lung Injury 67 Dalbavancin 67 Rheumatoid Arthritis Drug 66 Acute Decompensated Heart Failure 66 Antibacterials 66 metastatic malignant 66 GW# [003] 66 Adenomas 66 Preclinical Efficacy 66 Pneumococcal Disease 66 Microplasmin 66 Inhaled Liposomal Ciprofloxacin 66 Initiates Phase II 66 biliary tract cancer 66 Long Term Outcomes 66 Potent Antiviral Activity 66 Peripheral Arterial Disease 66 Valvular Heart Disease 66 Avian Flu Vaccine 66 Aortic Valve 66 Myeloid 66 Cancer Vaccine 66 Susceptibility Gene 66 Kidney Transplant Recipients 66 Inactivation 66 Tumor Suppressor 66 Interferon Gamma 66 Oxidative Stress 66 Bevacizumab 66 Prospective Multicenter 66 Molecular Diagnostic Test 66 Bone Marrow Cells 66 Significantly Improved 66 Test Detects 66 Cognitive Function 66 Genital Herpes 66 Pulmonary Hypertension 66 Tumor Cells 66 Long Term Survival 66 Parenteral Nutrition 66 Renal Anemia 66 Cancer Immunotherapy 66 familial amyloidotic polyneuropathy FAP 66 Asthma COPD 66 STRIDE PD 66 advanced hepatocellular carcinoma 66 Dapagliflozin 66 Pre Cancerous 66 Glucocorticoid 66 CT Angiography 66 samarium Sm 66 Sapacitabine 66 Rhinosinusitis 66 Partial Onset Seizures 66 Pralatrexate 66 Universal Flu Vaccine 66 Temsirolimus 66 Clinical Study 66 Virus Linked 66 ARIXTRA R 66 Bronchiectasis 66 Benign Prostatic Hyperplasia BPH 66 Submits NDA 66 Exelixis XL# 66 Predict Breast Cancer 66 Phase Ib Clinical Trial 66 overactive bladder syndrome 66 Combination Vaccine 66 dual endothelin receptor antagonist 66 Plaque Psoriasis 66 Breast Cancer Stem Cells 66 BERKELEY CA UroToday.com 66 Hormone Receptor 66 First Patient Enrolled 66 Maribavir 66 Gaucher Disease 66 Hormone Therapy 66 Brain Tumors 66 Peginterferon Alfa 2b 66 Stem Cell Transplants 66 metastatic neuroendocrine tumors 66 Antifungals 66 ara C 66 Carcinomas 66 Advanced Ovarian Cancer 66 Viral Load 66 Mesothelioma Treatment 66 Liposomal 66 Androgen Receptor 66 ASCO GI 66 Gene Variant 66 Breast Tissue 66 Mucosal 66 Physician Insights 66 Randomized Controlled 66 Renal Cell Cancer 66 Intracerebral 66 Metastatic Cancer 66 FDA Accepts 66 Kidney Transplants 66 Etanercept 66 Anti Inflammatory Drug 66 Antibiotic Treatment 66 Robotic Assisted 66 Endothelial Cells 66 Gastric Ulcers 66 Hematopoietic Stem Cell Transplantation 66 Therapy Improves 66 Left Ventricular 66 Polymorphisms 66 Premenopausal Women 66 Tolerability 66 Observational Study 66 Chemoprevention 66 Crit Rev 66 Blood Pressure Drug 66 Anemia Drug 66 Tumor Markers 66 Potent Anti 66 Lenalidomide 66 Obesity Linked 66 Viral Infection 66 Adjuvanted 66 Pneumococcal Conjugate Vaccine 66 Gene Therapy Trial 66 Pegylated 66 TNF Alpha 66 AA Amyloidosis 66 Vaccine Shows Promise 66 Improve Outcomes 66 Multidrug Resistant 66 Tumor Cell 66 Aromatase Inhibitors 66 Breast Ultrasound 66 Fibroblast 66 Survival Rates 66 Colon Polyps 66 Chronic Lymphocytic Leukemia CLL 66 Stent Implantation 66 Childhood Leukemia 66 Factor VIIa 66 Diffuse Large B 66 Cancer Therapies 66 Autoantibodies 66 Multicenter Trial 66 Biomarker Study 66 Uterine Fibroids 66 Microspheres 66 Ebola Vaccine 66 Mantle Cell Lymphoma 66 Genetic Basis 66 Hepatic 66 Epithelial Cells 66 Metastatic Breast Cancer 66 Factor Receptor 66 Pharmacodynamics 66 Aptamer 66 Achieves Primary Endpoint 66 Newly Diagnosed Breast Cancer 66 Bare Metal Stent 66 Intravascular 66 Aneurysm Repair 66 Hepatitis C Genotype 66 Tesetaxel 66 Blood Cancers 66 Uterine Cancer 66 Lymphoma Patients 66 Initiate Phase II 66 Cutaneous Melanoma 66 Endometrial 66 Therapy Evaluation 66 Selective Internal 66 Brain Aneurysms 66 Dose Ranging 66 abacavir Ziagen 66 Cancer Incidence Mortality 66 BiTE Antibody 66 Combination Clinical Trial 66 Fallopian Tube 66 Neuroendocrine Tumor 66 NAVISTAR R 66 ARRY # 66 Hepatitis C Treatment 66 Genetic Markers 66 Randomised Controlled Trial 66 Atherosclerotic 66 Receives Orphan Drug 66 Polycythemia Vera 66 Preclinical Evaluation 66 Ischaemic 66 Antifungal 66 Regenerative Cells 66 Heart Transplant Recipients 66 CTAP# Capsules 66 monoclonal antibody conjugated 66 Initiates Phase 2b 66 EGFR HER2 66 Ozarelix 66 Romiplostim 66 Pancreatic Adenocarcinoma 66 Cholesterol Lowering 66 Chronic Rhinosinusitis 66 Enzyme Replacement Therapy 66 Amniotic Fluid 66 MKC# MKC# PP 66 Molecular Mechanism 66 Epilepsy Drugs 66 Mortality Risk 66 Glioblastoma Multiforme 66 Percutaneous Tibial Nerve Stimulation 66 Receptor Agonist 66 HeFH 66 Total Knee Arthroplasty 66 Migraine Treatment 66 Cancer Recurrence 66 Rheumatoid 66 Non Alcoholic Steatohepatitis 66 Drug Pipeline 66 Genetic Mutations 66 Relapsed Multiple Myeloma 66 Chronic Inflammation 66 Phase 2a Study 66 Malignancy 66 Patient Enrolment 66 Brentuximab Vedotin SGN 66 Hypertriglyceridemia 66 Hematopoietic Stem Cells 65 Psychiatric Disorders 65 Erythropoietic 65 STELARA TM 65 Breast Cancers 65 Therapy Reduces 65 Treat Anemia 65 Immune Cells 65 Pegylated Liposomal Doxorubicin 65 Treating Depression 65 Migraine Headaches 65 Darbepoetin Alfa 65 Granulocyte Colony Stimulating Factor 65 Initiates Enrollment 65 Archexin 65 Blinatumomab 65 Pandemic Flu Vaccine 65 Increased Risk 65 Pandemic Influenza Vaccines 65 Liprotamase 65 ORLive Presents 65 Gram Positive 65 Yondelis ® 65 Cytotoxic 65 Treatment Regimens